Vascular Biogenics Company
Vascular Biogenics Ltd operating as VBL Therapeutics is a publicly traded (NASDAQ: VBLT), late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of first-in-class treatments for cancer.
Technology:
B2B, Health Care
Industry:
AgeTech
Headquarters:
Modi’in, Israel
Founded Date:
2000
Employees Number:
Above 20
Funding Status:
N/A
Register and Claim Ownership